The cancer drugs that could improve survival rates if given to patients in the morning
dailym.ai -

A study has found that people with terminal lung or skin cancers lived twice as long if they received ­immunotherapy drugs - at the start of the day instead of after lunchtime.

Related Articles

Latest in News

More from dailym.ai | dailymail health Cancer France Paris